Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Forma Therapeutics Holdings, Inc. (FMTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/24/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 10/18/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 10/14/2022 |
4
| Lesser Brian Andrew (SVP, Commercial Officer) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 10,000 shares
@ $0
Unknown transaction of 42,593 shares
@ $0
Disposed/sold 32,987 options to buy
@ $5.05, valued at
$166.6k
Disposed/sold 17,533 options to buy
@ $5.05, valued at
$88.5k
Disposed/sold 46,756 options to buy
@ $5.43, valued at
$253.9k
Disposed/sold 46,756 options to buy
@ $20, valued at
$935.1k
Disposed/sold 36,850 options to buy
@ $38.61, valued at
$1.4M
Disposed/sold 37,500 options to buy
@ $9.86, valued at
$369.8k
|
|
| 10/14/2022 |
4
| Potts Jeannette (See Remarks) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 3,400 shares
@ $0
Unknown transaction of 43,958 shares
@ $0
Disposed/sold 111,746 options to buy
@ $5.05, valued at
$564.3k
Disposed/sold 11,689 options to buy
@ $5.05, valued at
$59k
Disposed/sold 105,201 options to buy
@ $5.43, valued at
$571.2k
Disposed/sold 72,004 options to buy
@ $20, valued at
$1.4M
Disposed/sold 43,550 options to buy
@ $38.61, valued at
$1.7M
Disposed/sold 37,500 options to buy
@ $9.86, valued at
$369.8k
|
|
| 10/14/2022 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 52,532 shares
@ $0
Unknown transaction of 7,250 shares
@ $0
Disposed/sold 14,026 options to buy
@ $5.05, valued at
$70.8k
Disposed/sold 28,053 options to buy
@ $5.43, valued at
$152.3k
Disposed/sold 17,533 options to buy
@ $20, valued at
$350.7k
Disposed/sold 8,375 options to buy
@ $25.35, valued at
$212.3k
Disposed/sold 6,750 options to buy
@ $6.12, valued at
$41.3k
|
|
| 10/14/2022 |
4
| Frederick Wayne A.I. (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 7,250 shares
@ $0
Disposed/sold 25,000 options to buy
@ $35, valued at
$875k
Disposed/sold 8,375 options to buy
@ $25.35, valued at
$212.3k
Disposed/sold 6,750 options to buy
@ $6.12, valued at
$41.3k
|
|
| 10/14/2022 |
4
| Lee Frank D. (President and CEO) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 201,436 shares
@ $0
Disposed/sold 678,357 options to buy
@ $5.05, valued at
$3.4M
Disposed/sold 70,134 options to buy
@ $5.05, valued at
$354.2k
Disposed/sold 748,100 options to buy
@ $5.43, valued at
$4.1M
Disposed/sold 71,770 options to buy
@ $20, valued at
$1.4M
Disposed/sold 175,875 options to buy
@ $38.61, valued at
$6.8M
Disposed/sold 182,500 options to buy
@ $9.86, valued at
$1.8M
|
|
| 10/14/2022 |
4
| MOLINA ARTURO MD (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 10,000 shares
@ $0
Disposed/sold 16,750 options to buy
@ $11.97, valued at
$200.5k
Disposed/sold 6,750 options to buy
@ $6.12, valued at
$41.3k
|
|
| 10/14/2022 |
4
| Melian Agustin (EVP, Research & Development) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 79,000 shares
@ $0
Disposed/sold 118,000 options to buy
@ $8.2, valued at
$967.6k
|
|
| 10/14/2022 |
4
| Bishop John E (SVP, Chief Technology Officer) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 47,950 shares
@ $0
Disposed/sold 67,000 options to buy
@ $24.26, valued at
$1.6M
Disposed/sold 38,930 options to buy
@ $9.86, valued at
$383.8k
|
|
| 10/14/2022 |
4
| Shegog Todd (SVP, CFO) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 56,143 shares
@ $0
Disposed/sold 153,528 options to buy
@ $5.05, valued at
$775.3k
Disposed/sold 11,689 options to buy
@ $5.05, valued at
$59k
Disposed/sold 116,890 options to buy
@ $5.43, valued at
$634.7k
Disposed/sold 70,134 options to buy
@ $20, valued at
$1.4M
Disposed/sold 50,250 options to buy
@ $38.61, valued at
$1.9M
Disposed/sold 50,000 options to buy
@ $9.86, valued at
$493k
|
|
| 10/14/2022 |
4
| WIGGANS THOMAS G (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 7,250 shares
@ $0
Disposed/sold 25,000 options to buy
@ $39.5, valued at
$987.5k
Disposed/sold 8,375 options to buy
@ $25.35, valued at
$212.3k
Disposed/sold 6,750 options to buy
@ $6.12, valued at
$41.3k
|
|
| 10/14/2022 |
4
| WIRTH PETER (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 127,665 shares
@ $0
Unknown transaction of 7,250 shares
@ $0
Disposed/sold 14,026 options to buy
@ $5.05, valued at
$70.8k
Disposed/sold 28,053 options to buy
@ $5.43, valued at
$152.3k
Disposed/sold 17,533 options to buy
@ $20, valued at
$350.7k
Disposed/sold 8,375 options to buy
@ $25.35, valued at
$212.3k
Disposed/sold 6,750 options to buy
@ $6.12, valued at
$41.3k
|
|
| 10/14/2022 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 23,590 shares
@ $0
Unknown transaction of 7,250 shares
@ $0
Disposed/sold 14,026 options to buy
@ $5.05, valued at
$70.8k
Disposed/sold 9,351 options to buy
@ $5.05, valued at
$47.2k
Disposed/sold 28,053 options to buy
@ $5.43, valued at
$152.3k
Disposed/sold 17,533 options to buy
@ $20, valued at
$350.7k
Disposed/sold 8,375 options to buy
@ $25.35, valued at
$212.3k
Disposed/sold 6,750 options to buy
@ $6.12, valued at
$41.3k
|
|
| 10/14/2022 |
SC 13D/A
| RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in FORMA THERAPEUTICS HOLDING, INC. |
| 10/14/2022 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 7,250 shares
@ $0
Unknown transaction of 7,500,226 shares
@ $0
Unknown transaction of 1,511,425 shares
@ $0
Disposed/sold 17,533 options to buy
@ $20, valued at
$350.7k
Disposed/sold 8,375 options to buy
@ $25.35, valued at
$212.3k
Disposed/sold 6,750 options to buy
@ $6.12, valued at
$41.3k
|
|
| 10/14/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/14/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 10/14/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/14/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/14/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/14/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/14/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/14/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 10/14/2022 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 10/07/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/07/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/28/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/28/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/19/2022 |
3/A
| Lesser Brian Andrew (SVP, Commercial) has filed a Form 3/A on Forma Therapeutics Holdings, Inc. |
| 09/15/2022 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 09/15/2022 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 09/02/2022 |
SC 13D/A
| RA CAPITAL MANAGEMENT, L.P. reports a 18.9% stake in FORMA THERAPEUTICS HOLDING, INC. |
|
|
|